
Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
Merck & Co’s decision to close down the former Organon facility in Oss, the Netherlands, looks set to be challenged …
Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …
Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …
Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …
Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …
Pfizer is reportedly planning to cut or relocate up to 1,400 jobs in New York in its on-going restructuring programme. …

Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …
Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …
GlaxoSmithKline is on the point of making the first job cuts in a round of redundancies designed to save £500 …
Pfizer has announced a cut of 20% to its US salesforce, a move it says will help it adapt to …